Industry
Medical - Instruments & Supplies
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.
Loading...
Open
21.43
Mkt cap
54M
Volume
1.2K
High
21.58
P/E Ratio
-0.62
52-wk high
23.41
Low
21.29
Div yield
N/A
52-wk low
5.34
Portfolio Pulse from Benzinga Insights
October 01, 2024 | 12:07 pm
Portfolio Pulse from Benzinga Insights
September 30, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
September 19, 2024 | 9:25 pm
Portfolio Pulse from Avi Kapoor
September 19, 2024 | 1:53 pm
Portfolio Pulse from Avi Kapoor
September 13, 2024 | 4:15 pm
Portfolio Pulse from Dylan Berman
September 13, 2024 | 3:21 pm
Portfolio Pulse from Benzinga Newsdesk
September 13, 2024 | 11:59 am
Portfolio Pulse from Benzinga Newsdesk
September 12, 2024 | 8:33 pm
Portfolio Pulse from Benzinga Newsdesk
September 12, 2024 | 8:32 pm
Portfolio Pulse from Benzinga Newsdesk
August 13, 2024 | 8:06 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.